[
  {
    "ts": "2025-10-28T14:36:00+00:00",
    "headline": "Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?",
    "summary": "DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.",
    "url": "https://finance.yahoo.com/news/dexcom-deliver-strong-q3-earnings-143600834.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "55284667-68e1-3b67-b2ac-576ccbd7a4ca",
      "content": {
        "id": "55284667-68e1-3b67-b2ac-576ccbd7a4ca",
        "contentType": "STORY",
        "title": "Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?",
        "description": "",
        "summary": "DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.",
        "pubDate": "2025-10-28T14:36:00Z",
        "displayTime": "2025-10-28T14:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d9f1cdae2096f5c50faaf4204585218d",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vYux4.kltUCik6dZyeJicA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d9f1cdae2096f5c50faaf4204585218d.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QdSX2OuDdnoC.G39z_DV.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d9f1cdae2096f5c50faaf4204585218d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-deliver-strong-q3-earnings-143600834.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-deliver-strong-q3-earnings-143600834.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-28T11:00:53+00:00",
    "headline": "Abbott Laboratories (NYSE:ABT) Shares Could Be 33% Above Their Intrinsic Value Estimate",
    "summary": "Key Insights The projected fair value for Abbott Laboratories is US$95.46 based on 2 Stage Free Cash Flow to Equity...",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-nyse-abt-shares-110053194.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ed75179e-9350-3436-8891-0b6f0cd13c92",
      "content": {
        "id": "ed75179e-9350-3436-8891-0b6f0cd13c92",
        "contentType": "STORY",
        "title": "Abbott Laboratories (NYSE:ABT) Shares Could Be 33% Above Their Intrinsic Value Estimate",
        "description": "",
        "summary": "Key Insights The projected fair value for Abbott Laboratories is US$95.46 based on 2 Stage Free Cash Flow to Equity...",
        "pubDate": "2025-10-28T11:00:53Z",
        "displayTime": "2025-10-28T11:00:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-nyse-abt-shares-110053194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-nyse-abt-shares-110053194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]